Print ISSN:-2394-6369

Online ISSN:-2394-6377


Current Issue

Year 2020

Volume: 7 , Issue: 2

Article Access statistics

Viewed: 54

Emailed: 0

PDF Downloaded: 37

International Journal of Clinical Biochemistry and Research

Evaluation of YKL-40, C- reactive protein and uric acid levels in hypertensive patients

Full Text PDF Share on Facebook Share on Twitter

Research Article

Author Details : K Balu Mahendran*, T Santhi

Volume : 7, Issue : 2, Year : 2020

Article Page : 168-171

Suggest article by email


Background: Hypertension is a major public health problem and leads to severe complications such as
cardiovascular disease, stroke, renal and other vascular complications. YKL-40 is a human glycoprotein
related to chitinase protein family encoded by chitinase 3-like 1 (CHI3L1) gene. Recently many studies
reported that YKL-40 play a role in the progression of atherosclerosis and other diseases. So, in this view
the present study focused to evaluate YKL-40 levels and to find out the association with C- reactive protein
(CRP) and uricacid in hypertensive patients.
Objectives : The present study was to assess YKL-40 levels in hypertensive patients compared with healthy
volunteers and to correlate these levels with C- Reactive protein and uricacid.
Materials and Methods: Fifty hypertensive patients with 35 to 50 years age group were selected according
to JNC-8 for this study and 50 healthy volunteers age matched subjects were selected as controls. Serum
YKL-40 and CRP was estimated by ELISA, uric acid and other routine investigations were carried out by
ERBA EM-360 fully automated analyzer.
Results: YKL-40, CRP, uricacid levels were significantly increased in hypertensive patients compared with
healthy volunteers. Serum YKL-40 levels positively correlated with CRP Uricacid, triglycerides, LDL,
systolic blood pressure and negative correlation with HDL cholesterol levels.
Conclusion: YKL-40 is considered as potential diagnostic marker for the assessment of vascular
complications in hypertension. Regular monitoring might be useful for reduction of vascular complications
in hypertensive patients. Further longitudinal studies are required for confirm it.

Keywords: Hypertension, YKL-40, C- reactive protein (CRP), Uric acid.

Doi : 10.18231/j.ijcbr.2020.036

How to cite : Mahendran K B , Santhi T , Evaluation of YKL-40, C- reactive protein and uric acid levels in hypertensive patients. Int J Clin Biochem Res 2020;7(2):168-171

Copyright © 2020 by author(s) and Int J Clin Biochem Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (